Total Payments
$3,876
2024 Payments
$14.08
Companies
32
Transactions
185
Medicare Patients
1,303
Medicare Billing
$148,942
Payment Breakdown by Category
Food & Beverage$3,317 (85.6%)
Education$559.48 (14.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,317 | 178 | 85.6% |
| Education | $559.48 | 7 | 14.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $596.33 | 28 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $486.40 | 28 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $397.24 | 23 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $322.75 | 5 | $0 (2019) |
| Millennium Pharmaceuticals, Inc. | $220.14 | 8 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $198.61 | 12 | $0 (2023) |
| Pharmacyclics LLC, An AbbVie Company | $189.90 | 4 | $0 (2021) |
| Genentech USA, Inc. | $171.01 | 4 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $145.70 | 11 | $0 (2019) |
| Astellas Pharma US Inc | $145.10 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14.08 | 1 | Genentech USA, Inc. ($14.08) |
| 2023 | $91.14 | 5 | AstraZeneca Pharmaceuticals LP ($21.70) |
| 2022 | $150.17 | 8 | Novartis Pharmaceuticals Corporation ($41.46) |
| 2021 | $90.86 | 3 | Pharmacyclics LLC, An AbbVie Company ($46.45) |
| 2019 | $997.98 | 47 | Amgen Inc. ($271.25) |
| 2018 | $1,224 | 63 | Amgen Inc. ($305.78) |
| 2017 | $1,308 | 58 | Millennium Pharmaceuticals, Inc. ($220.14) |
All Payment Transactions
185 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/12/2024 | Genentech USA, Inc. | Alecensa (Biological), Rozlytrek, Tecentriq | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: BioOncology | ||||||
| 11/08/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.80 | General |
| 11/02/2023 | RECORDATI_RARE_DISEASES_INC. | SYLVANT (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: ONCOLOGIC AGENT | ||||||
| 07/26/2023 | Amgen Inc. | Nplate (Biological), Vectibix, XGEVA | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Hematology | ||||||
| 05/17/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Oncology | ||||||
| 02/03/2023 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug), KISQALI | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Oncology | ||||||
| 08/16/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Education | In-kind items and services | $24.49 | General |
| Category: Oncology | ||||||
| 08/11/2022 | Myriad Genetic Laboratories, Inc. | myRisk (Device) | Food and Beverage | Cash or cash equivalent | $11.65 | General |
| Category: Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis | ||||||
| 06/16/2022 | Genentech USA, Inc. | GAZYVA (Biological), VENCLEXTA, POLIVY | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: BioOncology | ||||||
| 06/01/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $18.33 | General |
| Category: Oncology | ||||||
| 05/17/2022 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: ONCOLOGY | ||||||
| 04/27/2022 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug), TASIGNA | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: ONCOLOGY | ||||||
| 04/13/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $14.72 | General |
| Category: Oncology | ||||||
| 03/02/2022 | Myriad Genetic Laboratories, Inc. | myRisk (Device) | Food and Beverage | Cash or cash equivalent | $17.19 | General |
| Category: Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis | ||||||
| 09/22/2021 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA, PIQRAY | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: ONCOLOGY | ||||||
| 09/15/2021 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Hematology | ||||||
| 02/10/2021 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $46.45 | General |
| Category: ONCOLOGY | ||||||
| 08/02/2019 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 08/02/2019 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Education | In-kind items and services | $77.00 | General |
| Category: Immunology | ||||||
| 07/12/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $16.41 | General |
| Category: Oncology | ||||||
| 07/12/2019 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $12.01 | General |
| 06/14/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: ONCOLOGY | ||||||
| 06/12/2019 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Food and Beverage | Cash or cash equivalent | $15.29 | General |
| Category: Oncology | ||||||
| 06/08/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Oncology | ||||||
| 06/06/2019 | PFIZER INC. | MYLOTARG (Biological), BOSULIF, BESPONSA | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 332 | 596 | $87,411 | $51,624 |
| 2022 | 7 | 171 | 318 | $46,490 | $27,930 |
| 2021 | 18 | 686 | 14,524 | $159,981 | $60,683 |
| 2020 | 6 | 114 | 138 | $16,576 | $8,705 |
Total Patients
1,303
Total Services
15,576
Medicare Billing
$148,942
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 115 | 241 | $30,616 | $18,332 | 59.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 32 | 73 | $13,847 | $8,205 | 59.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 45 | $11,520 | $6,043 | 52.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 51 | $6,732 | $4,923 | 73.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 61 | $6,100 | $3,914 | 64.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 28 | 28 | $6,618 | $3,860 | 58.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 67 | $6,726 | $3,397 | 50.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 30 | $5,252 | $2,950 | 56.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 110 | $14,372 | $8,713 | 60.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 21 | 68 | $6,800 | $3,941 | 58.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 31 | $5,795 | $3,593 | 62.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 21 | $5,376 | $3,399 | 63.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 22 | 22 | $5,104 | $3,290 | 64.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $4,959 | $3,132 | 63.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 37 | $4,084 | $1,862 | 45.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 64 | 117 | $20,342 | $11,595 | 57.0% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2021 | 22 | 12,750 | $25,500 | $9,742 | 38.2% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 40 | 71 | $15,620 | $7,837 | 50.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 73 | 76 | $15,580 | $7,532 | 48.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 49 | 81 | $8,902 | $4,521 | 50.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 22 | $5,198 | $3,135 | 60.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 22 | 22 | $5,111 | $2,733 | 53.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 140 | 273 | $5,733 | $2,121 | 37.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 27 | 33 | $4,110 | $2,059 | 50.1% |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | Office | 2021 | 30 | 86 | $5,160 | $2,020 | 39.1% |
About Dr. Amy Calati, D.O
Dr. Amy Calati, D.O is a Internal Medicine healthcare provider based in Clinton Township, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2014. The National Provider Identifier (NPI) number assigned to this provider is 1942612577.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Calati, D.O has received a total of $3,876 in payments from pharmaceutical and medical device companies, with $14.08 received in 2024. These payments were reported across 185 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,317).
As a Medicare-enrolled provider, Calati has provided services to 1,303 Medicare beneficiaries, totaling 15,576 services with total Medicare billing of $148,942. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology, Medical Oncology
- Location Clinton Township, MI
- Active Since 06/02/2014
- Last Updated 05/15/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1942612577
Products in Payments
- SOLIRIS (Drug) $322.75
- OPDIVO (Biological) $298.45
- NINLARO (Drug) $162.35
- Imbruvica (Drug) $143.45
- EMPLICITI (Biological) $137.58
- Neulasta (Biological) $137.08
- KEYTRUDA (Biological) $127.42
- Avastin (Biological) $111.81
- ENTRESTO (Drug) $111.30
- ADCETRIS (Biological) $101.40
- IMFINZI (Drug) $90.03
- Lonsurf (Drug) $89.43
- ZYTIGA (Drug) $85.49
- Halaven (Drug) $83.30
- Kyprolis (Biological) $82.45
- Cabometyx (Drug) $68.03
- Xofigo (Drug) $62.50
- KISQALI (Drug) $58.61
- TAGRISSO (Drug) $50.80
- IMBRUVICA (Drug) $46.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Clinton Township
Edin Basic, D.o, D.O
Internal Medicine — Payments: $8,777
Internal Medicine $8,777
Linda Lu Kosal, D.o, D.O
Internal Medicine — Payments: $8,569
Internal Medicine $8,569
Bryan Eastes, Md, MD
Internal Medicine — Payments: $7,031
Internal Medicine $7,031
Dr. Harjeet Jhajj, D.o, D.O
Internal Medicine — Payments: $4,551
Internal Medicine $4,551
Elmoataz Ibrahim, M.d, M.D
Internal Medicine — Payments: $3,429
Internal Medicine $3,429
Dr. James Clinton, D.o, D.O
Internal Medicine — Payments: $3,079
Internal Medicine $3,079